Effectiveness Of Epidural Steroid Injection For Pain Management In Buerger's Disease: A Non-Operative Alternative For Refractory Patients
DOI:
https://doi.org/10.31004/jn.v10i1.54429Abstract
Background: Buerger’s disease (thromboangiitis obliterans) is a non-atherosclerotic, segmental vasculitis affecting small to medium-sized arteries and veins, strongly associated with tobacco use. Chronic ischemic pain is often challenging to manage despite pharmacologic and surgical options. Epidural steroid injection (ESI), commonly used for radicular pain, may modulate inflammatory and nociceptive pathways at the spinal level and provide benefit in ischemic pain. Case Presentation: A 34-year-old male with Buerger’s disease presented with severe refractory ischemic pain of the right lower extremity. CT angiography revealed distal occlusion of the right external iliac artery, stenosis of the left superficial femoral artery, and stenosis of the left anterior tibial artery. Despite treatment with NSAIDs, tramadol, vasodilators, aspirin, and iloprost infusion, pain relief was minimal (VAS 8/10). As the patient declined operative interventions, ESI was performed as a non-operative alternative. Significant improvement was noted (VAS reduced from 8 to 3 within 1 week) with enhanced functional mobility and no complications. Conclusion:ESI may serve as an effective adjunct for refractory ischemic pain in Buerger’s disease, especially in patients who are unwilling or unsuitable for surgical intervention.Downloads
Published
2026-01-31
How to Cite
Juanda, H., Asrial, R., & Jaya, I. (2026). Effectiveness Of Epidural Steroid Injection For Pain Management In Buerger’s Disease: A Non-Operative Alternative For Refractory Patients. Jurnal Ners, 10(1), 2369–2372. https://doi.org/10.31004/jn.v10i1.54429
Issue
Section
Articles
License
Copyright (c) 2026 Jurnal Ners

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the works authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journals published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).






